相关实验视频

Updated: Jun 12, 2025

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Published on: January 31, 2025

肢体和干部的形脂肉瘤:对一些人而不是所有人的多模式治疗?

William W Tseng¹, Francesco Barretta², Francesco Tucci^3,4

¹Department of Surgery, Division of Surgical Oncology, City of Hope National Medical Center, Duarte, California, USA.

Journal of surgical oncology

|September 27, 2024

概括

积极的手术和辐射疗法改善了形脂肪肉瘤 (PLPS) 的结果. 较小的,2级瘤可能仅通过手术治愈,而较大的瘤可能从化疗中受益.

科学领域:

手术瘤学手术瘤学
肉瘤研究研究肉瘤研究
癌症治疗结果的结果

背景情况:

形脂肪肉瘤 (PLPS) 是一种罕见的软组织肉瘤.
区分PLPS与其他脂质瘤亚型对于治疗规划至关重要.

研究的目的:

为了评估原发性,非转移性形脂肪瘤的外科治疗结果.
在PLPS管理中确定多模式治疗的潜在指示.

主要方法:

从44名PLPS患者 (2002-2019) 的临床病理数据的回顾性分析.
卡普兰-梅尔分析总生存 (OS),疾病特异性死亡 (DSD),局部复发 (LR) 和远程转移 (DM).
无变量模型评估了变量与结果之间的关联.

主要成果:

瘤的中位数大小为8.5厘米;75%是高等级 (FNCLCC等级3).
五年后的OS为75.3%;DSD为17.5%,LR为2.3%和DM为32.5%.
更大的瘤大小与更糟糕的OS和DSD相关. 一个较小的小组,2级瘤在单独手术后没有复发.

结论:

激进的手术和放射治疗对于PLPS的局部控制是有效的.
化疗可能对较大的瘤有益.
对于较小的,2级PLPS,仅仅手术可能就足够了,可能导致治愈.

关键词:

脂肪肉瘤 (liposarcoma) 是一种 pleomorphic 脂质肉瘤是一种多态的脂质肉瘤.软组织肉瘤软组织肉瘤

更多相关视频

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

相关概念视频

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...